Touch Medical Media
Touch Medical Media

Touch Medical Media

Leading the Debate on the Advances in Healthcare


AAN 2017 – Stuart Isaacson Interview

Prof. Stuart Isaacson, Editorial Board member for US Neurology, catches up with us to talk about his recent study in apomorphine subcutaneous injection to combat delayed onset of morning levodopa dose, in patients with morning akinesia. He also briefly covers the DaTscannin patients with suspected parkinsonian syndromes? Speaker disclosures: Honoraria for CME, consultant, research grants, and/or promotional speaker on behalf of: Abbvie, Acadia, Acorda, Adamas, Addex, Allergan, Amarantus, Auspex, Avid, Axovant, AZ Therapies, Biogen, Biotie, Britannia, Cynapsus, Eisai, Eli Lilly, GE Healthcare, Impax, Intec Pharma, Ipsen, Kyowa, Lundbeck, Medtronics, Merz, Michael J. Fox Foundation, Neurocrine, Neuroderm, NINDS/NIH, Parkinson Study Group, Pfizer, Pharma2B, Prothena, Roche, Sanofi, Shire, Sunovion, Teva, UCB, US World Meds, Xenoport. Filmed at the America Academy of Neurology (AAN) Annual Meeting, Boston, US, April 2017

Duration: 03:38
Licence: CC - Attribution
Original Language: English
Published: 5/4/2017
Diseases and Conditions: Parkinson's Disease
Format: Conference / Interviews / KOL

Other videos in this channel


Related Videos

AAN 2017 – Stuart Isaacson Interview

Comments (0)

Login to add your comment
Be the first to comment!